Yardena Samuels

Weizmann Institute of Science — Israel

Medicine · Health Sciences

55h-index21.9kcitations206works1.02yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Cancer Immunotherapy and Biomarkers(47), Cancer Genomics and Diagnostics(47), Immunotherapy and Immune Responses(45), Single-cell and spatial transcriptomics(32), Melanoma and MAPK Pathways(32)

Publications205 total

HLA export by melanoma cells decoys cytotoxic T cells to promote immune evasion
Cell·2025· 3 citedOpen Access
Lymphodepleting chemotherapy potentiates neoantigen-directed T cell therapy by enhancing antigen presentation
Cell Reports Medicine·2025Open Access
Recurrent Immunogenic Neoantigens and Their Cognate T-cell Receptors in Treatment-Resistant Metastatic Prostate Cancer
Cancer Discovery·2025· 1 citedOpen Access
Translation dysregulation in cancer as a source for targetable antigens
Cancer Cell·2025· 14 citedOpen Access
Supplementary Figure 3 from Temporal Genomic Analysis of Homogeneous Tumor Models Reveals Key Regulators of Immune Evasion in Melanoma
2025Open Access
Supplementary Table 3 from Temporal Genomic Analysis of Homogeneous Tumor Models Reveals Key Regulators of Immune Evasion in Melanoma
2025Open Access
Supplementary Figure 12 from Temporal Genomic Analysis of Homogeneous Tumor Models Reveals Key Regulators of Immune Evasion in Melanoma
2025Open Access
Supplementary Table 4 from Temporal Genomic Analysis of Homogeneous Tumor Models Reveals Key Regulators of Immune Evasion in Melanoma
2025Open Access
Supplementary Figure 10 from Temporal Genomic Analysis of Homogeneous Tumor Models Reveals Key Regulators of Immune Evasion in Melanoma
2025Open Access
Supplementary Figure 14 from Temporal Genomic Analysis of Homogeneous Tumor Models Reveals Key Regulators of Immune Evasion in Melanoma
2025Open Access
Supplementary Figure 16 from Temporal Genomic Analysis of Homogeneous Tumor Models Reveals Key Regulators of Immune Evasion in Melanoma
2025Open Access
Supplementary Tables- legends from Temporal Genomic Analysis of Homogeneous Tumor Models Reveals Key Regulators of Immune Evasion in Melanoma
2025Open Access
Supplementary Figure 5 from Temporal Genomic Analysis of Homogeneous Tumor Models Reveals Key Regulators of Immune Evasion in Melanoma
2025Open Access
Supplementary Figure 4 from Temporal Genomic Analysis of Homogeneous Tumor Models Reveals Key Regulators of Immune Evasion in Melanoma
2025Open Access
Supplementary Table 8 from Temporal Genomic Analysis of Homogeneous Tumor Models Reveals Key Regulators of Immune Evasion in Melanoma
2025Open Access
Supplementary Figure 6 from Temporal Genomic Analysis of Homogeneous Tumor Models Reveals Key Regulators of Immune Evasion in Melanoma
2025Open Access
Data from Temporal Genomic Analysis of Homogeneous Tumor Models Reveals Key Regulators of Immune Evasion in Melanoma
2025Open Access
Supplementary Figure 1 from Temporal Genomic Analysis of Homogeneous Tumor Models Reveals Key Regulators of Immune Evasion in Melanoma
2025Open Access
Supplementary Table 6 from Temporal Genomic Analysis of Homogeneous Tumor Models Reveals Key Regulators of Immune Evasion in Melanoma
2025Open Access
Supplementary Figure 13 from Temporal Genomic Analysis of Homogeneous Tumor Models Reveals Key Regulators of Immune Evasion in Melanoma
2025Open Access
page 1 of 11Next →

Frequent Co-authors

Steven A. Rosenberg(15), Victor E. Velculescu(11), Kenneth W. Kinzler(7), Bert Vogelstein(7), Todd D. Prickett(7), Eilon Barnea(7), Arie Admon(7), Jared J. Gartner(6), Xiaomu Wei(6), Shelly Kalaora(6), Ronen Levy(6), Eytan Ruppin(6), Jimmy Lin(5), Jamie K. Teer(5), Yishai Levin(5), Jennifer A. Wargo(5), Michael A. Davies(4), Joo Sang Lee(4), Julia C. Cronin(4), Nouar Qutob(4)